The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease

2008/09/07 by Krystyna Pawlak, Tomasz Domaniewski, Michal Mysliwiec +2 · 27 citations
Neuroscience · #Tryptophan and brain disorders #Stress Responses and Cortisol #Circadian rhythm and melatonin

paper · doi:10.1016/j.atherosclerosis.2008.08.014

Cited by

• Direct and Functional Biomarkers of Vitamin B6 Status
• Dextrorotatory kynurenine suppresses acute rejection through inhibiting M1 macrophage-mediated inflammation
• Regulation of superoxide dismutase genes: implications in disease. [europepmc]
• Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. [europepmc]
• Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo. [europepmc]
• The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. [europepmc]
• Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. [europepmc]
• Direct and Functional Biomarkers of Vitamin B6 Status. [europepmc]
• The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites. [europepmc]
• Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis. [europepmc]
• Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study. [europepmc]
• Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. [europepmc]
• The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders. [europepmc]
• A Mitochondria-Associated Oxidative Stress Perspective on Huntington's Disease. [europepmc]
• Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury. [europepmc]
• Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases. [europepmc]
• Plasma kynurenines and prognosis in patients with heart failure. [europepmc]
• Immune Dysfunction in Uremia 2020. [europepmc]
• The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis. [europepmc]
• Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism. [europepmc]
• Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD. [europepmc]
• Kynurenine pathway in kidney diseases. [europepmc]
• The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors. [europepmc]
• Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next? [europepmc]
• Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings? [europepmc]
• Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease. [europepmc]
• The Footprint of Kynurenine Pathway in Cardiovascular Diseases. [europepmc]